Live·Open questions in longevity research
Hypothesis Universe
Omega Point · Hypothesis

The strongest skin nerve signal may sustain a body-wide response through

In an , competition among signals from sites could let the strongest input sustain an . Confirmed that produces no dependence on would refute this proposed selection rule.

Stage of verification

  1. Hypothesis published2026-09-25
  2. Indirect evidenceAssessed at 4 of 10
  3. Direct testAwaited

Map of the hypothesis

Hover over an icon or tap it to see its name.

Where in the body

Main connectionBrain and nervous system

Biological function

The biological function description is being prepared

Direction

Lens

Puts the cause in what the system senses and how that signal is held and passed on, rather than in what it is made of.Information and sensing

Kind of knowledge gap

No current scientific result answers this requirement.Void gap

A double ring marks the main placement where a group contains several values.

Goal
Самоограничение регенерации при повторных циклах восстановления
Competing hypotheses
1
Published
2026-09-25
As a hypothesis
8 / 10Clarity of mechanism
8 / 10Few extra conditions
5 / 10Completeness of the answer
6 / 10Novelty of the idea
8 / 10Few new entities
8 / 10Decisive experiment
4 / 10Silver-bullet potential
4 / 10Support from research

Target map

Every target of every published hypothesis, each with the actions a hypothesis can propose on it. The targets and the actions of this hypothesis are drawn solid.

  1. Signalling pathway

    Sensory

    Nerve signals carrying sensory input from peripheral tissues into central sensory circuits

    Where this hypothesis acts sites with persistent

    Hypotheses on this target 7
    Sensory afferent activityInhibition. Hypotheses on this target 33Activation. Hypotheses on this target 0Desensitisation. Hypotheses on this target 0Function preservation. Hypotheses on this target 11Feedback restoration. Hypotheses on this target 11Rhythm restoration. Hypotheses on this target 0
    • Inhibition3
    • Activation
    • Desensitisation
    • Function preservation1
    • Feedback restoration1
    • Rhythm restoration

    What is proposed

    Inhibition

    Selectively and reversibly suppress sensory input from individual sites

    With whatSmall molecule

    HowSelective reversible suppression of individual afferent inputs in an ; in humans with control for direct inflammatory effects

    Possible result

    Expected reduction of the to the next strongest input, with decay after all inputs are silenced

    From the recordИзбирательное обратимое выключение чувствительной иннервации ведущего участка должно быстро снижать ответ до уровня второго по силе участка.

All targets of the lab

Every target read from the published hypotheses, each kind around its pictogram. A larger mark means more hypotheses act on that target. Point at a mark and the actions proposed on it branch out of it.

MoleculesAntibodies. Hypotheses on this target 3AntibodiesInterleukin-1α. Hypotheses on this target 3Interleukin-1αAmyloid seeds. Hypotheses on this target 2Amyloid seedsATP. Hypotheses on this target 2ATPCGRP. Hypotheses on this target 2CGRPHyaluronan. Hypotheses on this target 2HyaluronanInterleukin-1 receptor antagonist. Hypotheses on this target 2Interleukin-1 receptor antagonistInterleukin-6. Hypotheses on this target 2Interleukin-6Potassium. Hypotheses on this target 2PotassiumSpecialized pro-resolving lipid mediators. Hypotheses on this target 2Specialized pro-resolving lipid mediatorsAmmonia. Hypotheses on this target 1AmmoniaAntimicrobial peptides. Hypotheses on this target 1Antimicrobial peptidesBlood carbon dioxide. Hypotheses on this target 1Blood carbon dioxideBMP. Hypotheses on this target 1BMPCholesterol crystals. Hypotheses on this target 1Cholesterol crystalsCorticosterone. Hypotheses on this target 1CorticosteroneCryptic collagen ligands. Hypotheses on this target 1Cryptic collagen ligandsDKK1. Hypotheses on this target 1DKK1Double-stranded RNA. Hypotheses on this target 1Double-stranded RNAExtracellular electrolytes. Hypotheses on this target 1Extracellular electrolytesExtracellular histones. Hypotheses on this target 1Extracellular histonesFas ligand. Hypotheses on this target 1Fas ligandGlutamine. Hypotheses on this target 1GlutamineGlutathione. Hypotheses on this target 1GlutathioneHeavy chain–hyaluronan complexes. Hypotheses on this target 1Heavy chain–hyaluronan complexesHistamine. Hypotheses on this target 1HistamineInterleukin-10. Hypotheses on this target 1Interleukin-10Interleukin-22. Hypotheses on this target 1Interleukin-22Lipid A. Hypotheses on this target 1Lipid ALipid hydroperoxides. Hypotheses on this target 1Lipid hydroperoxidesM3 receptor autoantibodies. Hypotheses on this target 1M3 receptor autoantibodiesNAD+. Hypotheses on this target 1NAD+NKG2D ligands. Hypotheses on this target 1NKG2D ligandsNoggin. Hypotheses on this target 1NogginOxygen. Hypotheses on this target 1OxygenPeroxide. Hypotheses on this target 1PeroxidePGP-family peptides. Hypotheses on this target 1PGP-family peptidesPhenol-soluble modulins alpha (PSMα). Hypotheses on this target 1Phenol-soluble modulins alpha (PSMα)Phosphatidylserine. Hypotheses on this target 1PhosphatidylserinePlatelet-activating anti-PF4 immunoglobulin. Hypotheses on this target 1Platelet-activating anti-PF4 immunoglobulinProstaglandin E2. Hypotheses on this target 1Prostaglandin E2RNA–DNA hybrids. Hypotheses on this target 1RNA–DNA hybridsSenescent-cell secretions. Hypotheses on this target 1Senescent-cell secretionsSmall RNAs. Hypotheses on this target 1Small RNAsSoluble BCMA. Hypotheses on this target 1Soluble BCMAStratum corneum lipids. Hypotheses on this target 1Stratum corneum lipidsTacrolimus. Hypotheses on this target 1TacrolimusTGF-β1. Hypotheses on this target 1TGF-β1Tissue-binding antibodies. Hypotheses on this target 1Tissue-binding antibodiesTryptophan. Hypotheses on this target 1TryptophanTumstatin. Hypotheses on this target 1TumstatinVIP. Hypotheses on this target 1VIPWNT. Hypotheses on this target 1WNT
GenesRetroelements. Hypotheses on this target 3RetroelementsAcquired nuclear DNA. Hypotheses on this target 1Acquired nuclear DNAAntimicrobial protein coding sequences. Hypotheses on this target 1Antimicrobial protein coding sequencesExtrachromosomal DNA. Hypotheses on this target 1Extrachromosomal DNAHerpes simplex virus genomes. Hypotheses on this target 1Herpes simplex virus genomesHLA-II expression. Hypotheses on this target 1HLA-II expressionHormone-response regulatory variant combinations. Hypotheses on this target 1Hormone-response regulatory variant combinationsIFT88. Hypotheses on this target 1IFT88IRF4 half-site CpG methylation at the TGFB1 enhancer. Hypotheses on this target 1IRF4 half-site CpG methylation at the TGFB1 enhancerUV photolesions. Hypotheses on this target 1UV photolesions
Enzymes and receptorsProteases. Hypotheses on this target 7ProteasesEP2 receptor. Hypotheses on this target 5EP2 receptorGLS1. Hypotheses on this target 5GLS1YAP. Hypotheses on this target 5YAPmTOR. Hypotheses on this target 4mTORERK. Hypotheses on this target 3ERKFAK. Hypotheses on this target 2FAKGlutamine synthetase. Hypotheses on this target 2Glutamine synthetasemTORC1. Hypotheses on this target 2mTORC1Myosin. Hypotheses on this target 2MyosinNK1 receptor. Hypotheses on this target 2NK1 receptorp300. Hypotheses on this target 2p30012-lipoxygenase. Hypotheses on this target 112-lipoxygenaseAcid sphingomyelinase. Hypotheses on this target 1Acid sphingomyelinaseACOD1. Hypotheses on this target 1ACOD1Acyloxyacyl hydrolase. Hypotheses on this target 1Acyloxyacyl hydrolaseADAR1. Hypotheses on this target 1ADAR1AKT. Hypotheses on this target 1AKTAlpha-adrenergic receptors. Hypotheses on this target 1Alpha-adrenergic receptorsAMPK. Hypotheses on this target 1AMPKAntiproteases. Hypotheses on this target 1AntiproteasesApoptotic caspases. Hypotheses on this target 1Apoptotic caspasesβ-arrestin-2. Hypotheses on this target 1β-arrestin-2CAD. Hypotheses on this target 1CADCatalase. Hypotheses on this target 1CatalaseCathepsins. Hypotheses on this target 1CathepsinsCD1a. Hypotheses on this target 1CD1aCD40. Hypotheses on this target 1CD40CD45. Hypotheses on this target 1CD45CD47. Hypotheses on this target 1CD47Collagen IV. Hypotheses on this target 1Collagen IVCollagen VII. Hypotheses on this target 1Collagen VIIDermal collagen I and III triple helices. Hypotheses on this target 1Dermal collagen I and III triple helicesDNA polymerase theta. Hypotheses on this target 1DNA polymerase thetaEGFR. Hypotheses on this target 1EGFReIF2α. Hypotheses on this target 1eIF2αExecutioner caspases. Hypotheses on this target 1Executioner caspasesFactor XIII. Hypotheses on this target 1Factor XIIIFcγRIIa. Hypotheses on this target 1FcγRIIaFibrin. Hypotheses on this target 1FibrinFibronectin. Hypotheses on this target 1FibronectinFilamin C. Hypotheses on this target 1Filamin CFKBP12. Hypotheses on this target 1FKBP12FPR2/ALX receptor. Hypotheses on this target 1FPR2/ALX receptorβ-glucocerebrosidase. Hypotheses on this target 1β-glucocerebrosidaseGlucose-6-phosphate dehydrogenase. Hypotheses on this target 1Glucose-6-phosphate dehydrogenaseHCMV Fc-binding proteins. Hypotheses on this target 1HCMV Fc-binding proteinsHistones. Hypotheses on this target 1HistonesHsp70. Hypotheses on this target 1Hsp70HSPB1. Hypotheses on this target 1HSPB1Hyaluronan synthase 2. Hypotheses on this target 1Hyaluronan synthase 2Interleukin-10 receptor. Hypotheses on this target 1Interleukin-10 receptorIntestinal alkaline phosphatase. Hypotheses on this target 1Intestinal alkaline phosphataseKCC2. Hypotheses on this target 1KCC2LOX. Hypotheses on this target 1LOXM3 muscarinic receptor. Hypotheses on this target 1M3 muscarinic receptorMast-cell chymase. Hypotheses on this target 1Mast-cell chymaseMetabolic enzymes. Hypotheses on this target 1Metabolic enzymesMYC. Hypotheses on this target 1MYCMyeloperoxidase. Hypotheses on this target 1MyeloperoxidaseN-homocysteinylated circulating fibrinogen. Hypotheses on this target 1N-homocysteinylated circulating fibrinogenNeutrophil elastase. Hypotheses on this target 1Neutrophil elastaseNitric oxide synthase. Hypotheses on this target 1Nitric oxide synthaseNK3 receptor. Hypotheses on this target 1NK3 receptorNKG2D receptor. Hypotheses on this target 1NKG2D receptorNOTUM. Hypotheses on this target 1NOTUMORF2. Hypotheses on this target 1ORF2PAR1. Hypotheses on this target 1PAR1PCMT1. Hypotheses on this target 1PCMT1PD-1. Hypotheses on this target 1PD-1PD-L1. Hypotheses on this target 1PD-L1Peptide–MHC complexes. Hypotheses on this target 1Peptide–MHC complexesPhosphofructokinase. Hypotheses on this target 1PhosphofructokinasePIEZO1. Hypotheses on this target 1PIEZO1Prostaglandin E2 receptors. Hypotheses on this target 1Prostaglandin E2 receptorsRibosomes. Hypotheses on this target 1RibosomesRNase H1. Hypotheses on this target 1RNase H1SIRT6. Hypotheses on this target 1SIRT6TIM-4. Hypotheses on this target 1TIM-4TLR2. Hypotheses on this target 1TLR2TRPV4. Hypotheses on this target 1TRPV4TSG-6. Hypotheses on this target 1TSG-6V8 protease. Hypotheses on this target 1V8 proteaseZAKα. Hypotheses on this target 1ZAKα
CellsSenescent fibroblasts. Hypotheses on this target 7Senescent fibroblastsSenescent cells. Hypotheses on this target 4Senescent cellsOvarian somatic cells. Hypotheses on this target 3Ovarian somatic cellsT cells. Hypotheses on this target 3T cellsCooperating dangerous cells in breast tissue. Hypotheses on this target 2Cooperating dangerous cells in breast tissueMacrophages. Hypotheses on this target 2MacrophagesSenescent stromal cells. Hypotheses on this target 2Senescent stromal cellsAdrenal zona fasciculata cells. Hypotheses on this target 1Adrenal zona fasciculata cellsAntigen-presenting cells. Hypotheses on this target 1Antigen-presenting cellsAPC-altered cells. Hypotheses on this target 1APC-altered cellsBasal cells. Hypotheses on this target 1Basal cellsCapillary mural cells. Hypotheses on this target 1Capillary mural cellsCD1a-reactive T cells. Hypotheses on this target 1CD1a-reactive T cellsCompeting cells. Hypotheses on this target 1Competing cellsCorticotrophs. Hypotheses on this target 1CorticotrophsDendritic cells. Hypotheses on this target 1Dendritic cellsDifferentiated cells. Hypotheses on this target 1Differentiated cellsDll1-positive secretory progenitors. Hypotheses on this target 1Dll1-positive secretory progenitorsEpithelial progenitor cells. Hypotheses on this target 1Epithelial progenitor cellsFibroadipogenic progenitor cells. Hypotheses on this target 1Fibroadipogenic progenitor cellsFibroblasts. Hypotheses on this target 1FibroblastsGroup 3 innate lymphoid cells. Hypotheses on this target 1Group 3 innate lymphoid cellsHepatocytes. Hypotheses on this target 1HepatocytesIntestinal epithelial cells. Hypotheses on this target 1Intestinal epithelial cellsLgr5-positive stem cells. Hypotheses on this target 1Lgr5-positive stem cellsMast cells. Hypotheses on this target 1Mast cellsMature absorptive epithelial cells. Hypotheses on this target 1Mature absorptive epithelial cellsMedullary thymic epithelial cells. Hypotheses on this target 1Medullary thymic epithelial cellsMesenchymal stromal cells. Hypotheses on this target 1Mesenchymal stromal cellsMyeloid-biased long-term hematopoietic stem cells. Hypotheses on this target 1Myeloid-biased long-term hematopoietic stem cellsMyeloid–tissue hybrid cells. Hypotheses on this target 1Myeloid–tissue hybrid cellsMyofibroblasts. Hypotheses on this target 1MyofibroblastsNeutrophils. Hypotheses on this target 1NeutrophilsNK cells. Hypotheses on this target 1NK cellsReparative cells. Hypotheses on this target 1Reparative cellsSenescent osteogenic cells. Hypotheses on this target 1Senescent osteogenic cellsStromal cells. Hypotheses on this target 1Stromal cellsThymic epithelial cells. Hypotheses on this target 1Thymic epithelial cellsTumor-reactive T cells. Hypotheses on this target 1Tumor-reactive T cells
Tissues and matrixExtracellular matrix. Hypotheses on this target 11Extracellular matrixCollagen fibers. Hypotheses on this target 6Collagen fibersSkin tissue. Hypotheses on this target 4Skin tissueElastin–fibrillin network. Hypotheses on this target 3Elastin–fibrillin networkSubcutaneous adipose tissue. Hypotheses on this target 2Subcutaneous adipose tissueAntigen deposits. Hypotheses on this target 1Antigen depositsArterial resistance. Hypotheses on this target 1Arterial resistanceBasement membranes. Hypotheses on this target 1Basement membranesCell neighborhood geometry. Hypotheses on this target 1Cell neighborhood geometryCell surface geometry. Hypotheses on this target 1Cell surface geometryCorneocyte intercellular contacts. Hypotheses on this target 1Corneocyte intercellular contactsEpidermal mechanical stress. Hypotheses on this target 1Epidermal mechanical stressHyaluronan-proteoglycan matrix. Hypotheses on this target 1Hyaluronan-proteoglycan matrixMechanical prestress. Hypotheses on this target 1Mechanical prestressMotor units. Hypotheses on this target 1Motor unitsSensory axons. Hypotheses on this target 1Sensory axonsStratum corneum. Hypotheses on this target 1Stratum corneumStromal contacts. Hypotheses on this target 1Stromal contactsTendon tissue. Hypotheses on this target 1Tendon tissueTissue compression. Hypotheses on this target 1Tissue compressionTissue hydrostatic pressure. Hypotheses on this target 1Tissue hydrostatic pressureTissue mechanical relaxation spectrum. Hypotheses on this target 1Tissue mechanical relaxation spectrumVenous capacitance. Hypotheses on this target 1Venous capacitanceWet contact network between skin, clothing and bedding. Hypotheses on this target 1Wet contact network between skin, clothing and bedding
ProcessesEfferocytosis. Hypotheses on this target 8EfferocytosisEpithelial barrier repair. Hypotheses on this target 6Epithelial barrier repairLipid peroxidation. Hypotheses on this target 6Lipid peroxidationProtein translation. Hypotheses on this target 6Protein translationCalcium phosphate mineral growth. Hypotheses on this target 4Calcium phosphate mineral growthInflammation resolution. Hypotheses on this target 4Inflammation resolutionInflammatory response. Hypotheses on this target 4Inflammatory responseVasomotor discharges. Hypotheses on this target 4Vasomotor dischargesActomyosin contraction. Hypotheses on this target 3Actomyosin contractionAntigen-receptor signaling. Hypotheses on this target 3Antigen-receptor signalingAntimicrobial immune functions. Hypotheses on this target 3Antimicrobial immune functionsCircadian phase distribution. Hypotheses on this target 3Circadian phase distributionMemory replay. Hypotheses on this target 3Memory replayMitophagy. Hypotheses on this target 3MitophagyScope inference. Hypotheses on this target 3Scope inferenceSleep continuity. Hypotheses on this target 3Sleep continuityThermal balance. Hypotheses on this target 3Thermal balanceTissue renewal timing. Hypotheses on this target 3Tissue renewal timingAntigen presentation. Hypotheses on this target 2Antigen presentationAntimicrobial memory. Hypotheses on this target 2Antimicrobial memoryAutophagy. Hypotheses on this target 2AutophagyBacteriophage replication. Hypotheses on this target 2Bacteriophage replicationBlood flow–sweat secretion synchrony. Hypotheses on this target 2Blood flow–sweat secretion synchronyBone remodeling. Hypotheses on this target 2Bone remodelingCell fusion. Hypotheses on this target 2Cell fusionCell proliferation. Hypotheses on this target 2Cell proliferationCell recruitment. Hypotheses on this target 2Cell recruitmentEndocrine fluctuations. Hypotheses on this target 2Endocrine fluctuationsFerroptosis. Hypotheses on this target 2FerroptosisGap junction communication. Hypotheses on this target 2Gap junction communicationOxidative capacity. Hypotheses on this target 2Oxidative capacityPolyploidization. Hypotheses on this target 2PolyploidizationPositional signaling. Hypotheses on this target 2Positional signalingTransepithelial water transport. Hypotheses on this target 2Transepithelial water transportAct-to-training handoff. Hypotheses on this target 1Act-to-training handoffActivator–inhibitor signaling. Hypotheses on this target 1Activator–inhibitor signalingAnabolism. Hypotheses on this target 1AnabolismAntibody–effector co-occupancy. Hypotheses on this target 1Antibody–effector co-occupancyAntigen cross-presentation. Hypotheses on this target 1Antigen cross-presentationAntigen processing. Hypotheses on this target 1Antigen processingAntimicrobial deployment–epithelial repair synchrony. Hypotheses on this target 1Antimicrobial deployment–epithelial repair synchronyAttention allocation. Hypotheses on this target 1Attention allocationAutomatic recommendation delivery. Hypotheses on this target 1Automatic recommendation deliveryAutonomic recovery. Hypotheses on this target 1Autonomic recoveryBacterial utilization of exogenous fatty acids. Hypotheses on this target 1Bacterial utilization of exogenous fatty acidsCalcium homeostasis. Hypotheses on this target 1Calcium homeostasisCalcium signal decoding. Hypotheses on this target 1Calcium signal decodingCandidate/source binding. Hypotheses on this target 1Candidate/source bindingCardiovagal baroreflex. Hypotheses on this target 1Cardiovagal baroreflexCargo-mediated pathogen transfer. Hypotheses on this target 1Cargo-mediated pathogen transferCathelicidin carbamylation. Hypotheses on this target 1Cathelicidin carbamylationCausal test-selection policy. Hypotheses on this target 1Causal test-selection policyCell competition. Hypotheses on this target 1Cell competitionCell-cycle entry. Hypotheses on this target 1Cell-cycle entryCell membrane repair. Hypotheses on this target 1Cell membrane repairCell survival signaling. Hypotheses on this target 1Cell survival signalingCellular–antibody response timing. Hypotheses on this target 1Cellular–antibody response timingCentrosome organization. Hypotheses on this target 1Centrosome organizationcGAS–STING signaling. Hypotheses on this target 1cGAS–STING signalingChromatin programme of chronic secretion. Hypotheses on this target 1Chromatin programme of chronic secretionCoagulation cascade. Hypotheses on this target 1Coagulation cascadeCollagen crosslinking. Hypotheses on this target 1Collagen crosslinkingColonocyte metabolism. Hypotheses on this target 1Colonocyte metabolismCommunicative planning. Hypotheses on this target 1Communicative planningCommunity-conditioned modification of reconstruction. Hypotheses on this target 1Community-conditioned modification of reconstructionCompeting action accessibility. Hypotheses on this target 1Competing action accessibilityCompetitive drug displacement. Hypotheses on this target 1Competitive drug displacementComplement cascade. Hypotheses on this target 1Complement cascadeConcurrent incompatible-update reconciliation. Hypotheses on this target 1Concurrent incompatible-update reconciliationConvention compatibility. Hypotheses on this target 1Convention compatibilityCue-to-intention binding. Hypotheses on this target 1Cue-to-intention bindingCulture-to-risk feedback. Hypotheses on this target 1Culture-to-risk feedbackCutaneous vasodilation. Hypotheses on this target 1Cutaneous vasodilationDefault-preserving meta-choice. Hypotheses on this target 1Default-preserving meta-choiceDNA integration. Hypotheses on this target 1DNA integrationDNA repair. Hypotheses on this target 1DNA repairDNA replication licensing. Hypotheses on this target 1DNA replication licensingEnactment-cost feedback. Hypotheses on this target 1Enactment-cost feedbackEndocrine–circadian phase relationship. Hypotheses on this target 1Endocrine–circadian phase relationshipEndothelium-dependent vasodilation. Hypotheses on this target 1Endothelium-dependent vasodilationEntity correspondence. Hypotheses on this target 1Entity correspondenceEpidermal sealing–dermal remodeling synchrony. Hypotheses on this target 1Epidermal sealing–dermal remodeling synchronyEpidermal turnover. Hypotheses on this target 1Epidermal turnoverER-selective autophagy. Hypotheses on this target 1ER-selective autophagyErythrocyte arrival timing. Hypotheses on this target 1Erythrocyte arrival timingExcitation–secretion coupling. Hypotheses on this target 1Excitation–secretion couplingExtracellular infectious particle stabilization. Hypotheses on this target 1Extracellular infectious particle stabilizationExtracellular vesicle clearance. Hypotheses on this target 1Extracellular vesicle clearanceFailure detection and handover. Hypotheses on this target 1Failure detection and handoverFibrinolysis. Hypotheses on this target 1FibrinolysisGlutamine–glutamate cycle. Hypotheses on this target 1Glutamine–glutamate cycleGYS1-NONO condensation. Hypotheses on this target 1GYS1-NONO condensationHexosamine biosynthesis. Hypotheses on this target 1Hexosamine biosynthesisHistone export. Hypotheses on this target 1Histone exportHorizontal nuclear DNA transfer. Hypotheses on this target 1Horizontal nuclear DNA transferHost oxidant production. Hypotheses on this target 1Host oxidant productionIgG Fc glycosylation. Hypotheses on this target 1IgG Fc glycosylationImmune surveillance. Hypotheses on this target 1Immune surveillanceImmune target discrimination. Hypotheses on this target 1Immune target discriminationInstruction-scope conversion. Hypotheses on this target 1Instruction-scope conversionInterpretation switching. Hypotheses on this target 1Interpretation switchingIntracellular protein clearance. Hypotheses on this target 1Intracellular protein clearanceKeratinocyte polarity. Hypotheses on this target 1Keratinocyte polarityLymphocyte–APC contact timing. Hypotheses on this target 1Lymphocyte–APC contact timingLysosomal membrane permeabilization. Hypotheses on this target 1Lysosomal membrane permeabilizationLysosomal peptidoglycan degradation. Hypotheses on this target 1Lysosomal peptidoglycan degradationLysosome reformation. Hypotheses on this target 1Lysosome reformationMacromolecular crowding. Hypotheses on this target 1Macromolecular crowdingMeal–activity timing. Hypotheses on this target 1Meal–activity timingMechanical interference among lymphocytes. Hypotheses on this target 1Mechanical interference among lymphocytesMechanical load–mitosis timing. Hypotheses on this target 1Mechanical load–mitosis timingMechanical loading. Hypotheses on this target 1Mechanical loadingMechanoradical production. Hypotheses on this target 1Mechanoradical productionMental accounting. Hypotheses on this target 1Mental accountingMicrobial chemical defense. Hypotheses on this target 1Microbial chemical defenseMitochondrial fusion. Hypotheses on this target 1Mitochondrial fusionMitochondrial maintenance. Hypotheses on this target 1Mitochondrial maintenanceMitochondrial proton leak. Hypotheses on this target 1Mitochondrial proton leakMitochondrial transfer. Hypotheses on this target 1Mitochondrial transferMitosis. Hypotheses on this target 1MitosisMitotic entry in basal keratinocytes. Hypotheses on this target 1Mitotic entry in basal keratinocytesMitotic synchrony. Hypotheses on this target 1Mitotic synchronyMnemonic retention demand. Hypotheses on this target 1Mnemonic retention demandMuscle fiber adaptation. Hypotheses on this target 1Muscle fiber adaptationMutagenesis. Hypotheses on this target 1MutagenesisNeurogenic vasodilation. Hypotheses on this target 1Neurogenic vasodilationNeurokinin signaling. Hypotheses on this target 1Neurokinin signalingNeuronal secretion. Hypotheses on this target 1Neuronal secretionNF-κB activation. Hypotheses on this target 1NF-κB activationNitrogen-processing reaction network. Hypotheses on this target 1Nitrogen-processing reaction networkOrganelle maintenance. Hypotheses on this target 1Organelle maintenanceOxidative metabolism. Hypotheses on this target 1Oxidative metabolismParacrine signal–response synchrony. Hypotheses on this target 1Paracrine signal–response synchronyPartner retention and sorting. Hypotheses on this target 1Partner retention and sortingPathogen export. Hypotheses on this target 1Pathogen exportPeptide conjugation. Hypotheses on this target 1Peptide conjugationPeroxide clearance. Hypotheses on this target 1Peroxide clearancePlatelet adhesion. Hypotheses on this target 1Platelet adhesionPost-injury illness cascades. Hypotheses on this target 1Post-injury illness cascadesPreference construction. Hypotheses on this target 1Preference constructionPrimary cilium assembly. Hypotheses on this target 1Primary cilium assemblyProspective time allocation. Hypotheses on this target 1Prospective time allocationProtein carbamylation. Hypotheses on this target 1Protein carbamylationPublic commitment to cultural propositions. Hypotheses on this target 1Public commitment to cultural propositionsReceptor signal integration. Hypotheses on this target 1Receptor signal integrationReciprocal phase resetting. Hypotheses on this target 1Reciprocal phase resettingRegeneration–immune recognition timing. Hypotheses on this target 1Regeneration–immune recognition timingRegulatory-cell cytotoxicity. Hypotheses on this target 1Regulatory-cell cytotoxicityRelational memory. Hypotheses on this target 1Relational memoryRenal tubular reabsorption. Hypotheses on this target 1Renal tubular reabsorptionRibosome assembly. Hypotheses on this target 1Ribosome assemblyRNA splicing. Hypotheses on this target 1RNA splicingScratch contact. Hypotheses on this target 1Scratch contactScratch motor program. Hypotheses on this target 1Scratch motor programSemantic rewriting. Hypotheses on this target 1Semantic rewritingSensory integration. Hypotheses on this target 1Sensory integrationSkin adhesion. Hypotheses on this target 1Skin adhesionSkin barrier repair. Hypotheses on this target 1Skin barrier repairSolar radiation absorption. Hypotheses on this target 1Solar radiation absorptionSource-conditioned reconstruction. Hypotheses on this target 1Source-conditioned reconstructionSpatial coordination of ERK signaling. Hypotheses on this target 1Spatial coordination of ERK signalingStromal cell–matrix mechanical coupling. Hypotheses on this target 1Stromal cell–matrix mechanical couplingSweat evaporation. Hypotheses on this target 1Sweat evaporationThermoregulatory feedback. Hypotheses on this target 1Thermoregulatory feedbackTissue growth. Hypotheses on this target 1Tissue growthTissue renewal cycles. Hypotheses on this target 1Tissue renewal cyclesTissue repair. Hypotheses on this target 1Tissue repairTranscription. Hypotheses on this target 1TranscriptionTranscription-factor partnerships. Hypotheses on this target 1Transcription-factor partnershipsTranscription–replication conflicts. Hypotheses on this target 1Transcription–replication conflictsTranscriptional priming in estrogen-responsive cells. Hypotheses on this target 1Transcriptional priming in estrogen-responsive cellsTranscriptional repression. Hypotheses on this target 1Transcriptional repressionTransdermal drug absorption. Hypotheses on this target 1Transdermal drug absorptionTransmission timing. Hypotheses on this target 1Transmission timingtRNA queuosine modification. Hypotheses on this target 1tRNA queuosine modificationUbiquitin-dependent proteasomal degradation. Hypotheses on this target 1Ubiquitin-dependent proteasomal degradationVariant competition and selection. Hypotheses on this target 1Variant competition and selectionVascular obstruction. Hypotheses on this target 1Vascular obstructionSensory afferent activity. Hypotheses on this target 7Sensory afferent activity
Microbial communitiesGut microbiota. Hypotheses on this target 3Gut microbiotaBacterial pathogens. Hypotheses on this target 1Bacterial pathogens
MeasurementsCultural transmission mechanism classification. Hypotheses on this target 9Cultural transmission mechanism classificationMenopause syndrome classification. Hypotheses on this target 5Menopause syndrome classificationSweat secretory response. Hypotheses on this target 5Sweat secretory responseCircadian phase. Hypotheses on this target 2Circadian phaseCognitive performance measurements. Hypotheses on this target 2Cognitive performance measurementsNyquist stability boundary. Hypotheses on this target 2Nyquist stability boundaryRecovery status classification. Hypotheses on this target 2Recovery status classificationAntibody neutralizing activity. Hypotheses on this target 1Antibody neutralizing activityApplied shear load. Hypotheses on this target 1Applied shear loadCausal-binding accessibility. Hypotheses on this target 1Causal-binding accessibilityClone size measurement. Hypotheses on this target 1Clone size measurementContractile exit assessment. Hypotheses on this target 1Contractile exit assessmentFunctional performance measurements. Hypotheses on this target 1Functional performance measurementsInvasion measurement. Hypotheses on this target 1Invasion measurementMitotically reactivatable infected cell count. Hypotheses on this target 1Mitotically reactivatable infected cell countmt-Keima signal. Hypotheses on this target 1mt-Keima signalOptical oxygen saturation estimate. Hypotheses on this target 1Optical oxygen saturation estimatePerfusion measurements. Hypotheses on this target 1Perfusion measurementsSemantic coding. Hypotheses on this target 1Semantic codingSkin ageing index. Hypotheses on this target 1Skin ageing indexSkin microdamage classification. Hypotheses on this target 1Skin microdamage classificationSkin redness. Hypotheses on this target 1Skin rednessSkin water evaporation measurement. Hypotheses on this target 1Skin water evaporation measurementTarget-specific immune response measurements. Hypotheses on this target 1Target-specific immune response measurementsTreatment response classification. Hypotheses on this target 1Treatment response classificationViable pathogen burden. Hypotheses on this target 1Viable pathogen burden

Solid and named: the targets of this hypothesis

Explore in depth

The logic

The train of thought that ends in this hypothesis. Each stage is the reason the next exists. The master question narrows to a goal, the goal to an unknown nobody has closed, the unknown to the hypothesis proposed here. Every step below says what it rests on and what carries it.

The descent, in plain words

Repeated skin treatments might keep the body responding after individual treated areas begin to recover. The unexpected move is to propose that one healing area's nerve signal controls that response at a time, with control passing to another area when the leader quiets. This is a proposal generated by the pipeline, not a measured result.

The proposed mechanism, link by link
  1. Healing skin is proposed to leave unusually responsive and firing without a new external stimulus.
  2. Signals from different sites are proposed to compete in the brain or spinal cord, allowing the strongest to dominate.
  3. The dominant input is proposed to drive the body's above its .
  4. When the leading input weakens, control is proposed to pass to the next strongest input rather than end with the first site's recovery.
  5. Successive leading sites are proposed to prolong changes in circulating immune-cell activity and the body-wide response.
  6. Blocking every contributing input is predicted to let the response decay rather than remain sustained by a stored nervous-system state.
A picture for it

Several rooms have alarms, but a shared speaker plays only the loudest one. Silencing that alarm lets the next loudest take over, so the speaker can keep sounding after the first room falls quiet.

Where the picture breaks: The shared speaker already has a rule for choosing one alarm. Whether skin signals are selected this way, and whether that selection changes immune activity, are precisely what remain unestablished.

  1. Master questionstep 01 of 04

    The goal is a therapy that restores the functional condition of middle-aged people's skin to that of young people's skin.

    Rests on: The supplied goal defines the desired outcome, but does not specify which skin functions would establish success.

    Stated in the chain
  2. Goal pillarstep 02 of 04

    Skin , the rebuilding of damaged tissue, may limit itself across repeated recovery cycles.

    Rests on: The preceding goal seeks younger skin function but does not identify repeated recovery cycles as the route to it.

    Leap

    The chain supplies no connection between restoring younger skin function and a limit arising from repeated .

  3. Gap questionstep 03 of 04

    Simultaneous healing at several skin sites might overwhelm removal of , substances that carry inflammation-related signals, and leave a body-wide aftereffect. Tracking their entry into and removal from the blood might predict safe overlap between treatments better than total treated area.

    Rests on: The preceding stage raises limits during repeated recovery but gives no mechanism involving the body's capacity to remove these substances.

    Leap

    Neither the preceding stage nor the supplied source evidence establishes overwhelmed removal as the cause of a body-wide aftereffect or establishes the proposed advantage over treated area.

  4. Hypothesisstep 04 of 04

    The strongest current nerve input from healing skin is proposed to dominate through , meaning that signals suppress competing signals in the brain or spinal cord. As one site quiets, another takes control, prolonging a , activity in the branch of automatic nervous control that mobilizes the body, and changing the activity of immune cells circulating in blood.S3

    Rests on: The proposal replaces the preceding question's removal bottleneck with competition among nerve inputs. Scientific Reports (2026) reported increased in cells after a mouse cheek burn on days 1 and 7; this supports injury-related nerve activity, but does not establish competition, handoff, body-wide effects, or transfer to humans. The supplied auction analogy contributes the rule that the strongest input wins, while the response's rise and decay remain biological assumptions.

    Supported by literature

What is carried, and what is not. The supplied screened evidence speaks to one of the six mechanism links: injury-related changes in responsiveness or ; the mouse burn observations in Scientific Reports (2026) support that starting point but not the downstream body-wide mechanism. None of the supplied sources establishes the sequence end to end, including selection of a leading site, handoff, immune effects, or a beneficial treatment schedule.

Where the reasoning is carried by something unstated · 2
  • Goal pillar. The chain supplies no connection between restoring younger skin function and a limit arising from repeated . Establish the missing link before relying on this step.
  • Gap question. Neither the preceding stage nor the supplied source evidence establishes overwhelmed removal as the cause of a body-wide aftereffect or establishes the proposed advantage over treated area. Establish the missing link before relying on this step.
How a result here could mislead · 3
  • Calling whichever site's causes the largest response the 'leading site' would make the strongest-input prediction circular. What closes it: Rank sites before using measured nerve firing and independently estimated signal transmission, as the proposal specifies. Compare leading-site and weaker-site , and verify that each intervention actually suppresses its intended nerve input.
  • A response after , medication that blocks sensation in a body region, could reflect the medication's direct effects on inflammation rather than removal of the proposed controlling signal. Reduced reported pain alone would also leave the body-wide claim untested. What closes it: The design requires a separate control for the medication's direct inflammatory effects and measurements of automatic nervous-system activity and inflammation alongside pain. The supplied specification acknowledges the medication problem but does not provide a concrete control.
  • A fall in the nervous response could be credited with ending the whole aftereffect while the rival immune mechanism continues. Matching inflammatory-substance entry and removal alone would not establish that the rival's circulating , clusters of antibodies bound to material they recognize, are matched. What closes it: Track the nervous response and inflammatory response separately, together with the rival's antibody-bound material and its activation of immune cells. After verified of all contributing inputs, assess decay against a timescale fixed before interpreting the result; the supplied material gives no numerical timescale.

What would make this wrong. With nerve-input strength ranked independently and selective confirmed, a response that does not depend on which site's input is strongest would contradict the central selection rule. Persistence of the nervous response beyond a pre-established decay period after all contributing inputs are demonstrably suppressed would contradict dependence on ongoing input. A reduction in pain alone, without the predicted nervous and inflammatory changes, would not support the proposed full chain.

What it would change. If this mechanism held, schedules for repeated skin recovery would need to account for how long successive nerve inputs maintain a body-wide response, alongside treated area and the movement of inflammatory substances. That would supply a possible scheduling constraint for pursuing younger skin function. It would still not establish restoration of middle-aged human skin, and the proposed benefit to cannot be interpreted because that outcome is not defined in the supplied material.

Sources read · 4

4 literature searches, 3 full texts, 1 abstract-only; 4 source(s) assessed against this question using the available text. A bounded search is not evidence of absence.

S1Partly answers it

Post-Burn Pruritus. · International journal of molecular sciences · 2020

“These nociceptors become sensitized and develop spontaneous activity when injured by diseases.”

Does not settle: The source does not establish competition among signals from multiple recovering skin sites, selection of a strongest signal, sympathetic dominance or handoff between sites. It also does not establish a body-wide autonomic response, changes in circulating immune-cell activity, a duration-limiting schedule, or effects on SPV_10.

S2Partly answers itAbstract only

Nociceptors: thermal allodynia and thermal pain. · Handbook of clinical neurology · 2018

“Mechanisms of thermal hyperalgesia include peripheral sensitization of nociceptor afferents and maladaptive changes in pain-encoding neurons within the central nervous system.”

Does not settle: Источник не устанавливает продолжающиеся разряды кожных афферентов, конкурентное торможение между участками, выбор ведущего сигнала, симпатический или вегетативный ответ, изменения циркулирующих иммунных клеток, системное последействие, его длительность или связь с SPV_10.

S3Partly answers it

Altered sensory neuron activity in a mouse model of post-burn pain and itch. · Scientific reports · 2026

“The proportion of TG neurons exhibiting spontaneous activity was significantly increased on day 1 after scald burn injury, corresponding to the peak of pain-related behaviors (Fig. ; Supplemental Fig. A; Supplementary Material ). Although the proportion of spontaneously active neurons on day 7, corresponding to the peak of itch-related behaviors, was lower than that observed on day 1, it remained significantly elevated compared with baseline levels”

Does not settle: This mouse cheek-burn study does not establish competition among signals from multiple recovering sites, central inhibitory mechanisms, sympathetic or body-wide effects, circulating immune-cell activity, transfer to humans, or effects of a schedule on SPV_10.

S4Partly answers it

Targeting GPR183 to reduce peripheral sensitization: evidence from rodent and human tissue analyses. · bioRxiv : the preprint server for biology · 2026

“In a well-characterized rat incisional injury model, GPR183 protein expression increased in injured paw tissue, and SAE-14 reversed hypersensitivity.”

Does not settle: Источник поддерживает связь повреждения ткани с периферической сенситизацией в модели крыс и описывает изменения экспрессии в человеческой коже после операции. Он не устанавливает продолжающиеся разряды кожных афферентов, конкурентное торможение в центральных сенсорных цепях, выбор ведущего сигнала, симпатический или иной системный вегетативный ответ, изменения циркулирующих иммунных клеток, последовательную смену участков или влияние расписания на SPV_10.

The gap this hypothesis explains

Nothing is known here: the question has not been asked of this system.

Does overlapping skin repair overwhelm inflammatory-signal removal, and does tracking amounts predict safety better than treated area?

Original wording · exactly as the pipeline generated it
The gap question, as the engine wrote it

Возникает ли одновременной участков кожи из-за , и предсказывает ли безопасное точнее суммарной площади лечения?

What this question is asking

The question concerns whether repairing several skin areas at overlapping times leaves effects elsewhere in the body after treatment. It asks whether inflammatory signals from those areas arrive faster than the body can remove them, allowing signals to accumulate between treatment cycles. It then asks whether accounting for signal production, removal and remaining amounts predicts safe overlap more accurately than adding up the treated skin area, including any contribution from processes outside the skin. The framing assumes that spacing treatments and lymphatic drainage are relevant to this problem, and sets a requirement that effects subside within specified days or weeks without residual accumulation; the supplied evidence establishes neither that timeframe nor a safe treatment schedule.

What the terms mean
Skin repair and regeneration
Skin repair is the process of healing damaged skin. implies restoration of tissue; the supplied wound-healing findings do not establish restoration to the functional state of young skin.
Inflammatory signals or mediators
A class of substances involved in coordinating inflammation, rather than one substance with one removal rate. The question does not specify which signals would be measured or counted.
Inflammation
A tissue response involved in injury and healing. The supplied material describes both a supporting role during healing and problems associated with persistence, so its presence alone does not define harm.
Systemic effects
Effects involving the body beyond the treated skin area. Here, persistent systemic effects mean effects continuing after treatment or into another treatment cycle; the input specifies no particular measurement.
Removal capacity and saturation
Removal capacity is how much of a signal can be removed over time. Saturation is the proposed condition in which removal cannot keep pace with additional input; it is not demonstrated by the supplied sources.
Mass balance
An accounting of how an amount changes through what enters or is produced and what leaves or is removed. Here it is a proposed way to track inflammatory signals remaining over time, not a validated safety model.
Treatment-cycle overlap
Timing in which another treatment or repair period begins while an earlier one is still having effects. It differs from the normal overlap of healing stages described within a wound.
Total treated area
The combined surface area of skin receiving treatment. It describes treatment extent but does not itself measure inflammatory-signal production or removal.
Lymphatic drainage
Movement of fluid away from tissues through the lymphatic system. Manual lymphatic drainage is a hands-on treatment intended to assist that movement; a change in drainage does not by itself quantify inflammatory-signal removal.
Macrophages
Immune cells involved in inflammation and tissue repair. The inflammation-promoting description in S6 identifies a functional state, not a permanently separate cell type.
Fibroblasts
Cells involved in making and maintaining tissue's supporting material. S6 reports that they support movement of skin-surface cells during healing.
Keratinocytes
Cells that form the skin's outer covering. Their movement helps restore coverage over a wound.
Neutrophils
Immune cells involved in the inflammatory response. S9 discusses their timely removal from the wound environment, which is a different measurement from removal of signal molecules.
What the question takes for granted
Premise not found in what was read
Spacing skin-repair cycles and lymphatic removal provide a basis for a schedule in which systemic effects resolve within days or weeks without residual accumulation, although the quantitative limit of mediator removal remains unknown.

The lymphatic system drains fluid from tissues, while treatment spacing determines how much repair happens at the same time. The framing treats these as relevant controls on inflammatory signals remaining elsewhere in the body between treatments. If that relationship were established, it could connect treatment timing to a measurable limit on accumulation.

The supplied search results do not establish this scheduling premise, a removal-capacity limit or the required recovery timeframe. S4 presents improved lymphatic drainage as part of the rationale for a wound-treatment study, rather than measuring whole-body removal of inflammatory signals. S5 reports that small changes in lymphatic function were not related to symptoms or signs in women after breast cancer surgery. Neither source establishes the proposed relationship for overlapping skin repair, and the internal references mentioned in the gap detail have no supplied source content. This absence of support does not establish that the premise is false.S4S5

The same question asked without the part nothing read establishes:

  • Does overlapping repair of several skin areas produce persistent effects elsewhere in the body, and are those effects associated with inflammatory-signal production exceeding removal?
  • Does accounting for inflammatory-signal production and removal predict safe overlap of skin-repair cycles more accurately than total treated area?
What turns on the answer
  • Removal is overwhelmed; tracking amounts predicts better Under the proposed mechanism, overlapping repair would make signal input exceed removal, leaving amounts that persist into later cycles. If accounting for those amounts also predicts safety better, treated area alone would omit information needed to distinguish safer from less safe overlap.
  • Removal is overwhelmed; predictive advantage is absent Accumulation could explain persistent effects without making the proposed calculation a better safety predictor. Establishing the mechanism would therefore not establish that the calculation improves scheduling compared with treated area.
  • Persistent effects occur without overwhelmed removal Effects elsewhere in the body could persist while the proposed removal bottleneck remains unestablished. A calculation built around that bottleneck would then lack a demonstrated explanation for the persistence, and its predictive value would remain a separate question.
  • No persistent effects are detected There would be no observed persistent effect for overloaded removal to explain under the conditions assessed. That outcome alone would establish neither safety under other treatment conditions nor a predictive advantage for accounting for signal amounts.
Why it matters

The proposed causal chain runs from overlapping skin repair to combined inflammatory-signal production, then potentially to insufficient removal, accumulation and persistent effects elsewhere in the body. Each connection would need support before this chain could explain treatment safety. If the chain holds, treated area alone could miss differences in timing, signal production or removal. If it does not hold, attributing persistent effects to overloaded removal could misidentify their cause, and a calculation based on that mechanism could give misleading reassurance.

What is already established

Разнесение участков по времени RL-3 и RL-1 не устанавливают количественный предел общего удаления .

What would have to be true

затухает за установленные дни или недели без остаточного накопления при допустимой площади и частоте восстановления.

What is missing

Отсутствует проверенная зависимость от площади, и , позволяющая обосновать выполнимое расписание.

The mechanism it proposes

The engine's own statement of the hypothesis, in full.

Проверяемая гипотеза: определяется выбором наиболее сильного текущего нервного сигнала от восстанавливающихся участков. в позволяет одному участку преимущественно задавать . Когда ведущий участок затихает, управление переходит к следующему. Несколько участков с длительной тем самым продлевают общий , который изменяет активность и поддерживает системные отклонения. Субстратом служат продолжающиеся и текущее конкурентное взаимодействие нервных сигналов. Расписание, ограничивающее продолжительность такого ответа, потенциально стабилизирует .

Where the idea comes from

The hypothesis borrows a result from another field. This is what it borrows, and from where.

и : правило выделения одного участнику с максимальной заявкой. : x*(t) = _x Σ_i b_i(t)x_i при x_i ∈ {0,1} и Σ_i x_i ≤ 1; b_i(t) = w_i r_i(t); τ·dy/dt = −y + g·max(0, max_i b_i(t) − b_0). Здесь i обозначает участок кожи; t — время; r_i — измеренную частоту его афферентных ; w_i — независимо оцененный этого участка; b_i — приведённую силу его нервного входа; x_i — выбор входа как ведущего; b_0 — ; y — измеряемую величину сверх ; g — ; τ — после выключения всех входов. Переносится правило распределения управления по максимальной заявке, описанное в ; денежные платежи и стратегическое поведение не постулируются. y является отдельным биологическим предположением. [Vickrey, Counterspeculation, Auctions, and Competitive Sealed Tenders](https://onlinelibrary.wiley.com/doi/full/10.1111/j.1540-6261.1961.tb02789.x).

Testing and possible results

The prediction that would tell it apart

A hypothesis that predicts what its rivals predict is not worth running an experiment over. This is the observation on which this one differs.

При одинаковой площади повреждения, сопоставимом поступлении в кровь и одинаковой скорости их удаления должен зависеть преимущественно от максимального . Избирательное обратимое выключение ведущего участка должно быстро снижать ответ до уровня второго по силе участка. Выключение более слабого участка должно давать существенно меньший эффект. После последовательного выключения всех участков ответ должен затухать без сохранения . Отсутствие зависимости от при подтверждённой опровергнет . Снижение только субъективной боли без изменений и воспалительных показателей также не подтвердит гипотезу.

States a measurable outcome; comparing rivals needs more conditions. The prediction specifies observable differences by site rank, response decay after blocking all sites, and an explicit rejection condition. These qualitative outcomes are measurable without numerical thresholds. No rival prediction is supplied. Only a bench experiment would settle it.

What testing it would take

The engine's own read on whether this is testable with methods that already exist.

целесообразно начинать в с регистрацией и избирательным обратимым подавлением отдельных входов. В исследовании человека возможны и регистрация показателей, но прямое действие на воспаление требует отдельного контроля. с одной лишь общей средой не воспроизводят центральную нервную часть механизма.

Other explanations

Every other hypothesis the engine wrote for the same gap, and the observation that would separate the two.

This hypothesis predicts

При одинаковой площади повреждения, сопоставимом поступлении в кровь и одинаковой скорости их удаления должен зависеть преимущественно от максимального . Избирательное обратимое выключение ведущего участка должно быстро снижать ответ до уровня второго по силе участка. Выключение более слабого участка должно давать существенно меньший эффект. После последовательного выключения всех участков ответ должен затухать без сохранения . Отсутствие зависимости от при подтверждённой опровергнет . Снижение только субъективной боли без изменений и воспалительных показателей также не подтвердит гипотезу.

  • What would separate them

    Healing antibodies may trigger systemic inflammation through circulating immune complexes predicts: В системе с , и активным варьируют перекрытие одинаковых повреждений и концентрацию , связывающих повреждённую ткань. Гипотеза предсказывает системного клеточного ответа от отношения . Максимум должен совпадать с появлением крупных , связывающих . Избирательное удаление этих должно снижать удалённую , одновременно замедляя локальное восстановление; добавление очищенных исходных должно возвращать оба эффекта. Фрагменты без при сопоставимом связывании не должны восстанавливать системный эффект. Отсутствие такой последовательности при подтверждённом удалении и восстановлении опровергнет предложенный механизм. Модель дополнительно проверяют независимым измерением его исчезновения после прекращения поступления.

What stands behind it

Which of the figures above have a study behind them, which are the engine's own, and what it would take to refute the hypothesis. This audit never judges the idea.

This hypothesis states no figure and cites no study, so there is nothing here to trace.

CitationsCites nothingFiguresnone statedPredictionStates a measurable outcome; comparing rivals needs more conditionsTo refuteOnly a bench experiment would settle it

What it would take to refute it. Nothing already retrieved carries the prediction’s terms and it names no measurement this layer can route to a public dataset, so the bench is the residual — not a finding against it.

0 citation handles extracted; 1 Europe PMC search run; 0 records examined; 0 sources stored for enrichment, 0 with full text. A citation that did not resolve is a bibliographic failure, not proof that no such paper exists, and no hypothesis is blocked by this audit.